Name | 4-Acetamido-N-tert-butylbenzamide |
---|---|
Synonyms |
4-Acetamido-N-(2-methyl-2-propanyl)benzamide
Benzamide, 4-(acetylamino)-N-(1,1-dimethylethyl)- MFCD00774476 4-Acetamido-N-tert-butylbenzamide CPI-1189 REN-1189 |
Description | CPI-1189 is a TNF-α release inhibitor with antioxidant and neuroprotective properties. CPI-1189 is used for researches of HIV-associated neurotoxicity and thus is a candidate for neuroprotective therapy in humans suffered from HIV-associated CNS disease[1][2]. |
---|---|
Related Catalog | |
References |
[1]. Müller T. CPI-1189. Centaur. Curr Opin Investig Drugs. 2002 Dec;3(12):1763-7. |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 458.3±28.0 °C at 760 mmHg |
Molecular Formula | C13H18N2O2 |
Molecular Weight | 234.294 |
Flash Point | 183.9±24.2 °C |
Exact Mass | 234.136826 |
LogP | 1.38 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.553 |
Storage condition | -20℃ |